13
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Cognition in Euthymic Patients with Bipolar Disorder: Do Not Forget to Account for Anxiety!

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 1181-1189 | Received 29 Dec 2023, Accepted 11 Apr 2024, Published online: 02 Jul 2024

References

  • Lima F, Rabelo-da-Ponte FD, Bücker J, et al. Identifying cognitive subgroups in bipolar disorder: a cluster analysis. J Affect Disord. 2019;246:252–261. doi:10.1016/j.jad.2018.12.044
  • Bortolato B, Miskowiak KW, Köhler CA, Vieta E, Carvalho AF. Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses. Neuropsychiatr Dis Treat. 2015;11:3111–3125. doi:10.2147/NDT.S76700
  • Martino DJ, Samamé C, Ibañez A, Strejilevich SA. Neurocognitive functioning in the premorbid stage and in the first episode of bipolar disorder: a systematic review. Psychiatry Res. 2015;226(1):23–30. doi:10.1016/j.psychres.2014.12.044
  • Lahera G, Ruiz-Murugarren S, Iglesias P, et al. Social cognition and global functioning in bipolar disorder. J Nerv Ment Dis. 2012;200(2):135. doi:10.1097/NMD.0b013e3182438eae
  • Martinez-Aran A, Vieta E, Torrent C, et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007;9(1–2):103–113. doi:10.1111/j.1399-5618.2007.00327.x
  • Martino DJ, Marengo E, Igoa A, et al. Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1 year follow-up study. J Affect Disord. 2009;116(1–2):37–42. doi:10.1016/j.jad.2008.10.023
  • Martino DJ, Igoa A, Marengo E, Scápola M, Strejilevich SA. Neurocognitive impairments and their relationship with psychosocial functioning in euthymic bipolar II disorder. J Nerv Ment Dis. 2011;199(7):459–464. doi:10.1097/NMD.0b013e3182214190
  • Bonnín CM, Martínez-Arán A, Torrent C, et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord. 2010;121(1):156–160. doi:10.1016/j.jad.2009.05.014
  • Mora E, Portella MJ, Forcada I, Vieta E, Mur M. Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol Med. 2013;43(6):1187–1196. doi:10.1017/S0033291712001948
  • Kessing LV. Cognitive impairment in the euthymic phase of affective disorder. Psychol Med. 1998;28(5):1027–1038. doi:10.1017/s0033291798006862
  • Mann-Wrobel MC, Carreno JT, Dickinson D. Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord. 2011;13(4):334–342. doi:10.1111/j.1399-5618.2011.00935.x
  • Martínez-Arán A, Vieta E, Reinares M, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161(2):262–270. doi:10.1176/appi.ajp.161.2.262
  • Zubieta JK, Huguelet P, O’Neil RL, Giordani BJ. Cognitive function in euthymic bipolar I disorder. Psychiatry Res. 2001;102(1):9–20.
  • Burdick KE, Ketter TA, Goldberg JF, Calabrese JR. Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design. J Clin Psychiatry. 2015;76(3):e342–e350. doi:10.4088/JCP.14cs09399
  • Benaiges I, Prat G, Adan A. Neuropsychological aspects of dual diagnosis. Curr Drug Abuse Rev. 2010;3(3):175–188. doi:10.2174/1874473711003030175
  • Albert U, Rosso G, Maina G, Bogetto F. Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Affect Disord. 2008;105(1–3):297–303. doi:10.1016/j.jad.2007.05.020
  • Gaudiano BA, Miller IW. Anxiety disorder comorbidity in Bipolar I Disorder: relationship to depression severity and treatment outcome. Depress Anxiety. 2005;21(2):71–77. doi:10.1002/da.20053
  • Keller MB. Prevalence and impact of comorbid anxiety and bipolar disorder. J Clin Psychiatry. 2006;67(Suppl 1):5–7.
  • Kinrys G, Bowden CL, Nierenberg AA, et al. Comorbid anxiety in bipolar CHOICE: insights from the bipolar inventory of symptoms scale. J Affect Disord. 2019;246:126–131. doi:10.1016/j.jad.2018.12.039
  • Otto MW, Simon NM, Wisniewski SR, et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006;189(01):20–25. doi:10.1192/bjp.bp.104.007773
  • Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Am J Psychiatry. 2004;161(12):2222–2229. doi:10.1176/appi.ajp.161.12.2222
  • Toprak E, Yavuz B. Anxiety disorders comorbidity in bipolar disorder patients and quality of life. J Mood Disord. 2011;1(2):55. doi:10.5455/jmood.20110619122123
  • Yoldi-Negrete M, Morera D, Palacios-Cruz L, et al. Subsyndromal anxiety: does it affect the quality of life? A study on euthymic patients with bipolar disorder. Eur J Psychiatr. 2019;33(4):159–164. doi:10.1016/j.ejpsy.2019.06.005
  • Moran TP. Anxiety and working memory capacity: a meta-analysis and narrative review. Psychol Bull. 2016;142(8):831–864. doi:10.1037/bul0000051
  • Wu HI, Chang YH, Lai CC, et al. The effect of comorbid anxiety disorder on neuropsychological function in bipolar II disorder. Prog Neuropsychopharmacol Biol Psychiatr. 2011;35(8):1841–1845. doi:10.1016/j.pnpbp.2011.07.013
  • Chang CT, Chang YH, Yung-Wei Wu J, et al. Neuropsychological functions impairment in different subtypes of bipolar disorder with or without comorbid anxiety disorders. Psychiatry Res. 2012;200(2–3):246–251. doi:10.1016/j.psychres.2012.06.012
  • Lu RB, Chang YH, Wang TY, Lee SY, Chen PS, Yang YK. The aldehyde dehydrogenase 2 polymorphisms on neuropsychological performance in bipolar II disorder with or without comorbid anxiety disorder. PLoS One. 2018;13(2):e0192229. doi:10.1371/journal.pone.0192229
  • Huang CJ, Lin CH, Wu JI, Yang WC. The relationship between depression symptoms and anxiety symptoms during acute ECT for patients with major depressive disorder. Int J Neuropsychopharmacol. 2019;22(10):609–615. doi:10.1093/ijnp/pyz038
  • Miskowiak K, Burdick K, Martinez-Aran A, et al. Assessing and addressing cognitive impairment in bipolar disorder: the international society for bipolar disorders targeting cognition task force recommendations for clinicians. Bipolar Disord. 2018;20(3):184–194. doi:10.1111/bdi.12595
  • Groves SJ, Douglas KM, Moot W, et al. Relationship between baseline cognition and 18-month treatment response in bipolar disorder. J Affect Disord. 2022;318:224–230. doi:10.1016/j.jad.2022.08.112
  • Kjærstad HL, Mistarz N, Coello K, et al. Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives. Psychol Med. 2020;50(11):1808–1819. doi:10.1017/S0033291719001867
  • Miskowiak K, Burdick K, Martinez-Aran A, et al. Methodological recommendations for cognition trials in bipolar disorder by the international society for bipolar disorders targeting cognition task force. Bipolar Disord. 2017;19(8):614–626. doi:10.1111/bdi.12534
  • Miskowiak KW, Petersen JZ, Ott CV, et al. Predictors of the discrepancy between objective and subjective cognition in bipolar disorder: a novel methodology. Acta Psychiatr Scand. 2016;134(6):511–521. doi:10.1111/acps.12649
  • Tohen M, Frank E, Bowden CCL, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009;11(5):453–473. doi:10.1111/j.1399-5618.2009.00726.x
  • Berlanga C, Cortés J, Bauer J. Adaptación y validación de la Escala de Depresión de Carroll en español [Adaptation and validation of the Carroll depression scale in spanish]. Salud Ment. 1992;15(4):36–40. Spanish.
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr. 1960;23:56–62.
  • Apiquian R, Péez F, Tapia RO, Fresán A, Vallejo G, Nicolini H. Validez y confiabilidad de la Escala para la Evaluacion de la Mania [Validity and reliability of the evaluation of mania scale]. Salud Ment. 1997;20(3):23–29. Spanish.
  • Cano-Vindel A, Muñoz-Navarro R, Moretti LS, Medrano LA. Propiedades psicométricas del Inventario de Situaciones y Respuestas de Ansiedad Breve (ISRA-B) [Psychometric properties of the brief inventory of situations and responses of anxiety (ISRA-B)]. Ansiedad Estrés. 2020;26(2):155–166. Spanish. doi:10.1016/j.anyes.2020.07.004
  • Cano-Vindel A, Miguel-Tobal JJ. Evaluación de la ansiedad desde un enfoque interactivo y multidimensional: el Inventario de Situaciones y Respuestas de Ansiedad (ISRA) [Evaluation of anxiety from an interactive and multidimensional focus: the Inventory of Situations and Responses of Anxiety (ISRA).]. Psicol Contemp. 1999;6(1):14–21. Spanish.
  • González-Ramírez MT, Del C Q-BL, Díaz-Rodríguez CL, Cano-Vindel A. Adaptación para México y estructura factorial del Inventario de Situaciones y Respuestas de Ansiedad Breve (ISRA-B) | [Adaptation to Mexico and factor structure of the Brief Inventory of Situations and Responses of Anxiety (ISRA-B)]. Ansiedad Estrés. 2014;20(1):89–100. Spanish.
  • Yoldi-Negrete M, Fresán-Orellana A, Martínez-Camarillo S, et al. Psychometric properties and cross-cultural comparison of the cognitive complaints in bipolar disorder rating assessment (COBRA) in Mexican patients with bipolar disorder. Psychiatry Res. 2018;269:536–541. doi:10.1016/j.psychres.2018.08.098
  • Lezak M. Neuropsychological Assessment. Oxford University Press; 2012. Available from: https://global.oup.com/academic/product/neuropsychological-assessment-9780195395525?cc=us&lang=en&. Accessed May 24, 2017.
  • Rivera D, Perrin PB, Stevens LF, et al. Stroop color-word interference test: normative data for the Latin American Spanish speaking adult population. NeuroRehabilitation. 2015;37(4):591–624. doi:10.3233/NRE-151281
  • Stroop GCJ. Test de Colores y Palabras – Edición Revisada. TEA Ediciones; 2020.
  • Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med. 2008;38(6):771–785. doi:10.1017/S0033291707001675
  • López-Jaramillo C, Lopera-Vásquez J, Gallo A, et al. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord. 2010;12(5):557–567. doi:10.1111/j.1399-5618.2010.00835.x
  • Samamé C, Martino D, Strejilevich S. Longitudinal course of cognitive deficits in bipolar disorder: a meta-analytic study. J Affect Disord. 2014;164:130–138. doi:10.1016/j.jad.2014.04.028
  • Eysenck MW, Derakshan N, Santos R, Calvo MG. Anxiety and cognitive performance: attentional control theory. Emot Wash DC. 2007;7(2):336–353. doi:10.1037/1528-3542.7.2.336
  • Teper R, Inzlicht M. Meditation, mindfulness and executive control: the importance of emotional acceptance and brain-based performance monitoring. Soc Cogn Affect Neurosci. 2013;8(1):85–92. doi:10.1093/scan/nss045
  • Shah S, Kim JP, Park DY, et al. Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder. J Affect Disord. 2017;219:165–171. doi:10.1016/j.jad.2017.05.007
  • Zutshi A, Reddy YCJ, Thennarasu K, Chandrashekhar CR. Comorbidity of anxiety disorders in patients with remitted bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2006;256(7):428–436. doi:10.1007/s00406-006-0658-2